MicroRNAs in lung diseases: Recent findings and their pathophysiological implications

Pulmonary Pharmacology and Therapeutics

Volumn 34, Issue , 2015, Pages 55-63

  Ebrahimi, Ammar ^a   Sadroddiny, Esmaeil ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asthma; COPD; Lung disease; MicroRNA; NSCLC

Indexed keywords

MICRORNA; AUTACOID;

ASTHMA; BIOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; LUNG CANCER; LUNG DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; GENETICS; INFLAMMATION; LUNG TUMOR; METABOLISM; PATHOPHYSIOLOGY;

ASTHMA; CYSTIC FIBROSIS; GENE EXPRESSION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG DISEASES; LUNG NEOPLASMS; MICRORNAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84943245850     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2015.08.007     Document Type: Review

References (85)

1. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
3. Lai E.C., Tomancak P., Williams R.W., Rubin G.M. Computational identification of Drosophila microRNA genes. Genome Biol. 2003, 4:R42.
4. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
5. Rahim F., Ebrahimi A. Gene therapy modalities in lung transplantation. Transpl. Immunol. 2014, 31:165-172.
6. Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 2009, 10:281-288.
7. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 2005, 6:376-385.
8. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr. Opin. Cell Biol. 2008, 20:214-221.
9. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc. Natl. Acad. Sci. 2007, 104:9667-9672.
10. O'Connell R.M., Rao D.S., Chaudhuri A.A., Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10:111-122.
11. Soriano J.B., Rodríguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc. Am. Thorac. Soc. 2011, 8:363-367.
12. Decramer M., Rennard S., Troosters T., Mapel D.W., Giardino N., Mannino D., et al. COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD Int. J. Chron. Obstruct. Pulmon. Dis. 2008, 5:235-256.
13. Sato T., Liu X., Nelson A., Nakanishi M., Kanaji N., Wang X., et al. Reduced miR-146a increases prostaglandin E2 in chronic obstructive pulmonary disease fibroblasts. Am. J. Respir. Crit. Care Med. 2010, 182:1020-1029.
14. Pottelberge G.R.V., Mestdagh P., Bracke K.R., Thas O., Durme YMv, Joos G.F., et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011, 183:898-906.
15. D'hulst A.I., Bracke K.R., Maes T., De Bleecker J.L., Pauwels R.A., Joos G.F., et al. Role of tumour necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur. Respir. J. 2006, 28:102-112.
16. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
17. Izzotti A., Calin G.A., Arrigo P., Steele V.E., Croce C.M., De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009, 23:806-812.
18. Schembri F., Sridhar S., Perdomo C., Gustafson A.M., Zhang X., Ergun A., et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. 2009, 106:2319-2324.
19. Izzotti A., Calin G.A., Steele V.E., Croce C.M., De Flora S. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 2009, 23:3243-3250.
20. Jardim M.J., Fry R.C., Jaspers I., Dailey L., Diaz-Sanchez D. Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ. Health Perspect. 2009, 117:1745-1751.
21. Ezzie M.E., Crawford M., Cho J.-H., Orellana R., Zhang S., Gelinas R., et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2011, thoraxjnl-2011-200089.
22. Lewis A., Riddoch-Contreras J., Natanek S.A., Donaldson A., Man W.D., Moxham J., et al. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 2012, 67:26-34.
23. Togo S., Holz O., Liu X., Sugiura H., Kamio K., Wang X., et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am. J. Respir. Crit. Care Med. 2008, 178:248-260.
24. Mattes J., Collison A., Plank M., Phipps S., Foster P.S. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl. Acad. Sci. 2009, 106:18704-18709.
25. Chiba Y., Tanabe M., Goto K., Sakai H., Misawa M. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am. J. Respir. Crit. Care Med. 2009, 180:713-719.
26. Tan Z., Randall G., Fan J., Camoretti-Mercado B., Brockman-Schneider R., Pan L., et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 2007, 81:829-834.
27. Mayoral R.J., Deho L., Rusca N., Bartonicek N., Saini H.K., Enright A.J., et al. MiR-221 influences effector functions and actin cytoskeleton in mast cells. PLoS One 2011, 6. e26133.
28. Martinez-Nunez R.T., Louafi F., Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α1 (IL13Rα1). J. Biol. Chem. 2011, 286:1786-1794.
29. Lu T.X., Munitz A., Rothenberg M.E. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J. Immunol. 2009, 182:4994-5002.
30. Pandit K.V., Corcoran D., Yousef H., Yarlagadda M., Tzouvelekis A., Gibson K.F., et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010, 182:220-229.
31. Liu G., Friggeri A., Yang Y., Milosevic J., Ding Q., Thannickal V.J., et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010, 207:1589-1597.
32. Nho R.S., Im J., Ho Y.-Y., Hergert P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 307:L632-L642.
33. Berschneider B., Ellwanger D.C., Baarsma H.A., Thiel C., Shimbori C., White E.S., et al. miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2014, 53:432-441.
34. Das S., Kumar M., Negi V., Pattnaik B., Prakash Y., Agrawal A., et al. MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2014, 50:882-892.
35. Zhang B., Liu T., Wu T., Wang Z., Rao Z., Gao J. microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. Int. J. Biol. Macromol. 2015, 74:111-118.
36. Shan N., Shen L., Wang J., He D., Duan C. MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19. Biochem. Biophys. Res. Commun. 2015, 456:385-391.
37. Yu Sh, Zhang Cl, Dong Fs, Zhang Ym miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway. J. Cell Biochem. 2015, 116:268-276.
38. Ma Z.-L., Hou P.-P., Li Y.-L., Wang D.-T., Yuan T.-W., Wei J.-L., et al. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2. Tumor Biol. 2014, 1-10.
39. Zhong K., Chen K., Han L., Li B. microRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer 2014, 14:703.
40. Yang Y., Liu L., Zhang Y., Guan H., Wu J., Zhu X., et al. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer. Int. J. Cancer 2014, 135:1531-1542.
41. Li J., Li P., Chen T., Gao G., Chen X., Du Y., et al. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. Tumor Biol. 2014, 1-8.
42. Xia Y., Zhu Y., Ma T., Pan C., Wang J., He Z., et al. miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC. FEBS Lett. 2014, 588:3703-3712.
43. Gu Y., Cheng Y., Song Y., Zhang Z., Deng M., Wang C., et al. MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1. PLoS One 2014, 9:e102602.
44. Mei Z., He Y., Feng J., Shi J., Du Y., Qian L., et al. MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. FEBS Lett. 2014, 588:3055-3061.
45. Chatterjee A., Chattopadhyay D., Chakrabarti G. miR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Cell Signal. 2015, 27:189-203.
46. Pan B., Chen Y., Song H., Xu Y., Wang R., Chen L. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Oncotarget 2014, 6(1):317-331.
47. Han H.S., Son S.-M., Yun J., Jo Y.N., Lee O.-J. MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6. FEBS Lett. 2014, 588:3744-3750.
48. Jasinski-Bergner S., Stehle F., Gonschorek E., Kalich J., Schulz K., Huettelmaier S., et al. Identification of 14-3-3β gene as a novel miR-152 target using a proteome-based approach. J. Biol. Chem. 2014, 289:31121-31135.
49. Xu L.-f., Wu Z.-p., Chen Y., Zhu Q.-s., Hamidi S., Navab R. MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One 2014, 9:e103698.
50. Perry M.M., Moschos S.A., Williams A.E., Shepherd N.J., Larner-Svensson H.M., Lindsay M.A. Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 2008, 180:5689-5698.
51. Jin Y., Pang T., Nelin L.D., Wang W., Wang Y., Yan J., et al. MKP-1 is a target of miR-210 and mediate the negative regulation of miR-210 inhibitor on hypoxic hPASMC proliferation. Cell Biol. Int. 2015, 39:113-120.
52. Hassan F., Nuovo G.J., Crawford M., Boyaka P.N., Kirkby S., Nana-Sinkam S.P., et al. MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PLoS One 2012, 7:e50837.
53. Megiorni F., Cialfi S., Cimino G., De Biase R.V., Dominici C., Quattrucci S., et al. Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients. J. Cyst. Fibros. 2013, 12:797-802.
54. Oglesby I.K., Bray I.M., Chotirmall S.H., Stallings R.L., O'Neill S.J., McElvaney N.G., et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J. Immunol. 2010, 184:1702-1709.
55. Lu T.X., Hartner J., Lim E.-J., Fabry V., Mingler M.K., Cole E.T., et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 2011, 187:3362-3373.
56. Rao P.K., Kumar R.M., Farkhondeh M., Baskerville S., Lodish H.F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. 2006, 103:8721-8726.
57. Chen J.-F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
58. Watford W.T., Moriguchi M., Morinobu A., O'Shea J.J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003, 14:361-368.
59. Case S.R., Martin R.J., Jiang D., Minor M.N., Chu H.W. MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp. Lung Res. 2011, 37:500-508.
60. Collison A., Mattes J., Plank M., Foster P.S. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 2011, 128:160-167. e4.
61. Patrick D.M., Montgomery R.L., Qi X., Obad S., Kauppinen S., Hill J.A., et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 2010, 120:3912.
62. Collison A., Herbert C., Siegle J.S., Mattes J., Foster P.S., Kumar R.K. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm. Med. 2011, 11:29.
63. Larner-Svensson H.M., Williams A.E., Tsitsiou E., Perry M.M., Jiang X., Chung K.F., et al. Pharmacological studies of the mechanism and function of interleukin-1β-induced miRNA-146a expression in primary human airway smooth muscle. Respir. Res. 2010, 11:68.
64. Williams A.E., Larner-Svensson H., Perry M.M., Campbell G.A., Herrick S.E., Adcock I.M., et al. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009, 4:e5889.
65. Polikepahad S., Knight J.M., Naghavi A.O., Oplt T., Creighton C.J., Shaw C., et al. Proinflammatory role for let-7 microRNAS in experimental asthma. J. Biol. Chem. 2010, 285:30139-30149.
66. Kumar M., Ahmad T., Sharma A., Mabalirajan U., Kulshreshtha A., Agrawal A., et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J. Allergy Clin. Immunol. 2011, 128:1077-1085. e10.
67. Chiba Y., Misawa M. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J. Pharm. Sci. 2010, 114:264-268.
68. Lin P., Yu S., Yang P. MicroRNA in lung cancer. Br. J. Cancer 2010, 103:1144-1148.
69. Skrzypski M., Dziadziuszko R., Jassem J. MicroRNA in lung cancer diagnostics and treatment. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2011, 717:25-31.
70. Wang Y., Lee C.G. MicroRNA and cancer-focus on apoptosis. J. Cell Mol. Med. 2009, 13:12-23.
71. Yu S.-L., Chen H.-Y., Chang G.-C., Chen C.-Y., Chen H.-W., Singh S., et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
72. Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin. Chem. 2008, 54:1696-1704.
73. Toledo F., Bardot B. Cancer: three birds with one stone. Nature 2009, 460:466-467.
74. Weiss G., Bemis L., Nakajima E., Sugita M., Birks D., Robinson W., et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 2008, mdn006.
75. Pandit K.V., Milosevic J., Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl. Res. 2011, 157:191-199.
76. Pottier N., Maurin T., Chevalier B., Puisségur M.-P., Lebrigand K., Robbe-Sermesant K., et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009, 4:e6718.
77. Louafi F., Martinez-Nunez R.T., Sanchez-Elsner T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β. J. Biol. Chem. 2010, 285:41328-41336.
78. Yang S., Banerjee S., de Freitas A., Sanders Y.Y., Ding Q., Matalon S., et al. Participation of miR-200 in pulmonary fibrosis. Am. J. Pathol. 2012, 180:484-493.
79. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2003, 168:918-951.
80. Kreindler J.L. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol. Ther. 2010, 125:219-229.
81. Greene C.M., Carroll T.P., Smith S.G., Taggart C.C., Devaney J., Griffin S., et al. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 2005, 174:1638-1646.
82. Tsuchiya M., Kumar P., Bhattacharyya S., Chattoraj S., Srivastava M., Pollard H.B., et al. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells. J. Interferon Cytokine Res. 2013, 33:121-129.
83. Ramachandran S., Karp P.H., Osterhaus S.R., Jiang P., Wohlford-Lenane C., Lennox K.A., et al. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am. J. Respir. Cell Mol. Biol. 2013, 49:544-551.
84. Ramachandran S., Karp P.H., Jiang P., Ostedgaard L.S., Walz A.E., Fisher J.T., et al. A microRNA network regulates expression and biosynthesis of wild-type and δF508 mutant cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. 2012, 109:13362-13367.
85. Amato F., Seia M., Giordano S., Elce A., Zarrilli F., Castaldo G., et al. Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis?. PLoS One 2013, 8:e60448.